MET and neoplasm: Through MET signaling, the tumor survives under hypoxic conditions [4], fights immune attacks [5,6], resists radiotherapy and chemotherapy [7,8], and sustains the clonal expansion occurring after resistance to targeted treatments [9,10,11].